WEED Stock Overview
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Canopy Growth Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$10.79 |
| 52 Week High | CA$26.00 |
| 52 Week Low | CA$3.74 |
| Beta | 2.03 |
| 1 Month Change | 108.30% |
| 3 Month Change | 83.82% |
| 1 Year Change | -40.71% |
| 3 Year Change | -96.75% |
| 5 Year Change | -98.34% |
| Change since IPO | -58.34% |
Recent News & Updates
More Unpleasant Surprises Could Be In Store For Canopy Growth Corporation's (TSE:WEED) Shares After Tumbling 28%
Feb 23
Analysts Have Been Trimming Their Canopy Growth Corporation (TSE:WEED) Price Target After Its Latest Report
Feb 13Recent updates
More Unpleasant Surprises Could Be In Store For Canopy Growth Corporation's (TSE:WEED) Shares After Tumbling 28%
Feb 23Analysts Have Been Trimming Their Canopy Growth Corporation (TSE:WEED) Price Target After Its Latest Report
Feb 13Why We're Not Concerned Yet About Canopy Growth Corporation's (TSE:WEED) 42% Share Price Plunge
Dec 22Is Canopy Growth (TSE:WEED) A Risky Investment?
Sep 17With A 31% Price Drop For Canopy Growth Corporation (TSE:WEED) You'll Still Get What You Pay For
Apr 17Is Canopy Growth (TSE:WEED) Using Too Much Debt?
Mar 21Earnings Update: Canopy Growth Corporation (TSE:WEED) Just Reported And Analysts Are Trimming Their Forecasts
Feb 12Is Canopy Growth (TSE:WEED) Using Too Much Debt?
Dec 08Shareholder Returns
| WEED | CA Pharmaceuticals | CA Market | |
|---|---|---|---|
| 7D | -3.1% | -4.9% | -1.9% |
| 1Y | -40.7% | 55.7% | 3.7% |
Return vs Industry: WEED underperformed the Canadian Pharmaceuticals industry which returned 55.7% over the past year.
Return vs Market: WEED underperformed the Canadian Market which returned 3.7% over the past year.
Price Volatility
| WEED volatility | |
|---|---|
| WEED Average Weekly Movement | 28.6% |
| Pharmaceuticals Industry Average Movement | 14.1% |
| Market Average Movement | 9.1% |
| 10% most volatile stocks in CA Market | 18.3% |
| 10% least volatile stocks in CA Market | 3.1% |
Stable Share Price: WEED's share price has been volatile over the past 3 months.
Volatility Over Time: WEED's weekly volatility (29%) has been stable over the past year, but is still higher than 75% of Canadian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2009 | 1,621 | David Klein | www.canopygrowth.com |
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company’s products include dried cannabis flower, extracts and concentrates, beverages, gummies, and vapes.
Canopy Growth Corporation Fundamentals Summary
| WEED fundamental statistics | |
|---|---|
| Market cap | CA$983.13m |
| Earnings (TTM) | -CA$1.18b |
| Revenue (TTM) | CA$362.24m |
2.7x
P/S Ratio-0.8x
P/E RatioIs WEED overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| WEED income statement (TTM) | |
|---|---|
| Revenue | CA$362.24m |
| Cost of Revenue | CA$322.10m |
| Gross Profit | CA$40.15m |
| Other Expenses | CA$1.22b |
| Earnings | -CA$1.18b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -12.95 |
| Gross Margin | 11.08% |
| Net Profit Margin | -325.76% |
| Debt/Equity Ratio | 112.4% |
How did WEED perform over the long term?
See historical performance and comparison